Assessing vascular senescence in zebrafish.

Area of Science:

• Neuroscience
• Developmental Biology
• Gerontology

Background:

• Zebrafish are a valuable model for studying age-dependent diseases due to their gradual senescence.
• Cerebral amyloid angiopathy (CAA) is a human neurovascular disease linked to amyloid-beta (Aβ) deposition, causing early stroke and vascular degeneration.
• Endothelial cell senescence is implicated in vascular aging and disease.

Purpose of the Study:

• To investigate if amyloid-beta (Aβ) peptides induce endothelial cell senescence during early zebrafish development.
• To establish methods for studying cell senescence in zebrafish embryos.

Main Methods:

• Exposure of whole-mount zebrafish embryos to Aβ peptides.
• Measurement of β-galactosidase activity as a senescence biomarker.
• Assessment of p21 expression using in situ hybridization in whole-mount embryos.

Main Results:

• Amyloid-beta peptides were shown to promote vascular senescence in zebrafish embryos at an early developmental stage.
• Increased β-galactosidase activity and p21 expression indicated premature aging of vascular cells.
• These findings suggest Aβ-induced senescence is an early indicator of vascular dysfunction.

Conclusions:

• Amyloid-beta peptides can induce vascular cell senescence during early zebrafish development.
• The zebrafish model allows for the study of early-onset vascular aging and related diseases.
• The described methods provide a framework for investigating cell senescence in zebrafish embryos.